Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2005-08-30
2005-08-30
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S490000, C424S491000, C424S493000
Reexamination Certificate
active
06936279
ABSTRACT:
Zeaxanthin (ZX) or other medically or commercially important carotenoids can be prepared in microcrystalline form, in an oily carrier liquid, to increase their bioavailability following oral ingestion. Initial processing is carried out to prepare a “rough” or “coarse-grained” carotenoid preparation containing relatively large particles of the ZX or other carotenoid, in a suitable form such as a lyophilized stable powder. The coarse-grain preparation is dissolved in a suitable solvent such as tetrahydrofuran, and mixed with a carrier liquid comprising a digestible oil (such as a vegetable oil) and an emulsifying agent. The resulting oil-and-solvent mixture is injected, along with inert gas such as nitrogen, into a vacuum chamber, where a suitable vacuum and temperature combination is used to remove the solvent in a rapid “flash” manner which does not give the carotenoid crystals time to grow larger through accretion or aggregation. This generates a microcrystalline suspension containing very small particles of the ZX or other cartenoid, in the oily liquid carrier. This product can be further processed if desired, or it can be loaded directly into watertight capsules for oral ingestion. Tests on human volunteers have confirmed that the bioavailability of this microcrystalline form is substantially higher than prior art preparations having larger particles of the carotenoid.
REFERENCES:
patent: 4522743 (1985-06-01), Horn et al.
patent: 4726955 (1988-02-01), Horn et al.
patent: 4851339 (1989-07-01), Hills
patent: 5118511 (1992-06-01), Horn et al.
patent: 5180747 (1993-01-01), Matsuda et al.
patent: 5290605 (1994-03-01), Shapira
patent: 5350773 (1994-09-01), Schweikert et al.
patent: 5356636 (1994-10-01), Schneider et al.
patent: 5545414 (1996-08-01), Behr et al.
patent: 5827652 (1998-10-01), Garnett et al.
patent: 5876754 (1999-03-01), Wunderlich et al.
patent: 5968251 (1999-10-01), Auweter et al.
patent: 6007856 (1999-12-01), Cox et al.
patent: 6235315 (2001-05-01), Runge et al.
patent: 6271396 (2001-08-01), Auweter et al.
patent: 6296877 (2001-10-01), Auweter et al.
patent: 6372782 (2002-04-01), Patel et al.
patent: 6406735 (2002-06-01), Stein et al.
patent: 6444227 (2002-09-01), Leuenberger et al.
patent: 6689400 (2004-02-01), Majeed
patent: 1 066 761 (2001-01-01), None
patent: WO 01/19383 (2001-03-01), None
Greenbury Dale K.
Guerra-Santos Luis H.
Kelly Patrick D.
Page Thurman K.
Young Micah-Paul
Zeavision LLC
LandOfFree
Microcrystalline zeaxanthin with high bioavailability in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Microcrystalline zeaxanthin with high bioavailability in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Microcrystalline zeaxanthin with high bioavailability in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3502008